Skip to main content

AgeX Therapeutics, Inc. (AGE)

NYSEAMERICAN: AGE · IEX Real-Time Price · USD
0.385
-0.006 (-1.53%)
Dec 29, 2023, 4:00 PM EST - Market closed

AgeX Therapeutics Revenue

AgeX Therapeutics had revenue of $94.00K in the twelve months ending September 30, 2023, with 77.36% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $67.00K with 644.44% year-over-year growth. In the year 2022, AgeX Therapeutics had annual revenue of $34.00K, a decrease of -76.39%.

Revenue (ttm)
$94.00K
Revenue Growth
+77.36%
P/S Ratio
155.44
Revenue / Employee
$18,800
Employees
5
Market Cap
14.61M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202234.00K-110.00K
-76.39%
Dec 31, 2021144.00K-217.00K
-60.11%
Dec 31, 2020361.00K-1.37M
-79.11%
Dec 31, 20191.73M332.00K
23.78%
Dec 31, 20181.40M-8.00K
-0.57%
Dec 31, 20171.40M-262.00K
-15.73%
Dec 31, 20161.67M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
American Shared Hospital Services 20.66M
Renalytix 2.89M
NeurAxis 2.54M
BioCardia 570.00K
Oragenics 37.65K
Lipocine -3.07M
Revenue Rankings

AGE News

More News